Cargando…

Apomorphine: The Initial Indian Experience in Relation to Response Tests and Pumps

BACKGROUND: Apomorphine is an option for continuous dopaminergic therapy in Parkinson's disease (PD). However, its effects in varied populations are limited due to its availability. OBJECTIVE: To assess the efficacy and outcomes of apomorphine in Indian patients. MATERIALS AND METHODS: Retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prashanth, LK, Jaychandran, R, Seetharam, Raghavendra, Iyer, Rajesh B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001430/ https://www.ncbi.nlm.nih.gov/pubmed/32055117 http://dx.doi.org/10.4103/aian.AIAN_428_19

Ejemplares similares

Looking Beyond the Fog—Apomorphine Demystified
por: LK, Prashanth, et al.
Publicado: (2020)

Clarithromycin-induced Seizures and Status Epilepticus
por: Seetharam, Raghavendra, et al.
Publicado: (2021)

Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience
por: Metta, Vinod, et al.
Publicado: (2023)

COVID-19 outcomes in persons with multiple sclerosis treated with rituximab
por: Iyer, Rajesh B, et al.
Publicado: (2022)

Apomorphine
Publicado: (1900)

Apomorphine
Publicado: (1888)

How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature
por: Isaacson, Stuart H., et al.
Publicado: (2022)

Apomorphine effects on the hippocampus
por: Arroyo-García, Luis Enrique, et al.
Publicado: (2018)

On the Anæsthetic Action of Apomorphine
Publicado: (1885)

Some Observations on the Use of Apomorphine
por: Horsley, J. S.
Publicado: (1912)

Is Apomorphine a Safe Emetic?
por: Brown, John
Publicado: (1889)

Ictal PET in presurgical workup of refractory extratemporal epilepsy
por: Nooraine, Javeria, et al.
Publicado: (2013)

Apomorphine Hydrochloride in the Treatment of Persistent Hiccough
por: Panda, R. C.
Publicado: (1928)

Apomorphine formulation may influence subcutaneous complications from continuous subcutaneous apomorphine infusion in Parkinson’s disease
por: Hagell, Peter, et al.
Publicado: (2020)

Population pharmacokinetic analysis of apomorphine sublingual film or subcutaneous apomorphine in healthy subjects and patients with Parkinson’s disease
por: Agbo, Felix, et al.
Publicado: (2021)

The Pharmacological Properties and Therapeutic Use of Apomorphine
por: Ribarič, Samo
Publicado: (2012)

Apomorphine in Parkinson's Disease—The Questions Raised
por: Dhamija, Rajinder K., et al.
Publicado: (2020)

Necrotic Ulcers Secondary to Apomorphine Infusion
por: Llamas-Osorio, Yudy, et al.
Publicado: (2021)

Systematic Review of the Apomorphine Challenge Test in the Assessment of Dopaminergic Activity in Schizophrenia
por: Duval, Fabrice
Publicado: (2023)

Investigation into the Action of Apomorphin as an Emetic in Its Physiological and Therapeutic Relations
por: Riegel, Franz, et al.
Publicado: (1872)

Effect of apomorphine on cognitive performance and sensorimotor gating in humans
por: Schellekens, Arnt F. A., et al.
Publicado: (2009)

A Case of Hiccough Cured with Apomorphine Hydrochloride
por: Dutt, K. N.
Publicado: (1933)

Apomorphine Targets the Pleiotropic Bacterial Regulator Hfq
por: Turbant, Florian, et al.
Publicado: (2021)

Dopamine-transporter levels drive striatal responses to apomorphine in Parkinson's disease
por: Passamonti, Luca, et al.
Publicado: (2013)

Feasibility and benefits of home initiation of subcutaneous apomorphine infusion for patients with Parkinson’s disease: the APOKADO study
por: Zagnoli, Fabien, et al.
Publicado: (2023)

Autosomal recessive bilateral frontal polymicrogyria with ectopia lentis and chorioretinal dystrophy
por: Nooraine, Javeria, et al.
Publicado: (2013)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
por: Antonini, Angelo
Publicado: (2009)

Au nanoparticle-based sensor for apomorphine detection in plasma
por: Zanchi, Chiara, et al.
Publicado: (2015)

Stability of apomorphine in solutions containing selected antioxidant agents
por: Ang, Zen Yang, et al.
Publicado: (2016)

Task Specific Tremor in Parkinson’s Disease Responds to Apomorphine
por: Ondo, William G., et al.
Publicado: (2023)

Night‐Time Apomorphine Infusion: Who Are the Best Candidates?
por: Cochen De Cock, Valérie, et al.
Publicado: (2023)

Apomorphine Monotherapy for Parkinson’s Disease: A Neglected Option?
por: Desjardins, Clément, et al.
Publicado: (2023)

Home initiation of apomorphine infusion: lessons from the COVID-19 pandemic and implications for current clinical practice
por: Kobylecki, Christopher, et al.
Publicado: (2023)

Posterior quadrant disconnection for refractory epilepsy: A case series
por: Nooraine, Javeria, et al.
Publicado: (2014)

Practical use of apomorphine infusion in Parkinson’s disease: lessons from the TOLEDO study and clinical experience
por: Henriksen, Tove, et al.
Publicado: (2023)

Relationship of Dopamine of the Nucleus Accumbens with Intra-infralimbic Apomorphine Microinjection
por: Alimoradian, Abbas, et al.
Publicado: (2013)

Apomorphine Subcutaneous Injection for the Management of Morning Akinesia in Parkinson's Disease
por: Isaacson, Stuart, et al.
Publicado: (2016)

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future
por: Auffret, Manon, et al.
Publicado: (2018)

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
por: Carbone, Federico, et al.
Publicado: (2019)

Investigation of apomorphine during sleep in Parkinson’s: Improvement in UPDRS Scores
por: Pieroni, Miguel A.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6lronnv5sep2g1q5tpn4jd1hbr